14 results
P
patients with rare disease, caregivers
I/C
health-related quality of life (HRQOL), other chronic disease groups, general population in Hong Kong
O
lower HRQOL
P
lung disease, li, ipf
I/C
baicalin, no intervention
O
reduced inflammation, decreased apoptosis, protected against progression
P
NSCLC patients
I/C
Xiao-ai-ping injection (XAPI) + platinum-based chemotherapy, platinum-based chemotherapy alone
O
objective tumor response rate (ORR), Karnofsky performance scores (KPS), occurrence of grade 3/4 leukopenia, anemia, thrombocytopenia, nausea and vomiting, immune function (CD8)
P
patients with liver lesions
I/C
LI-RADS algorithm, original studies reporting probability of LR-M for HCC and non-HCC malignancy on MRI
O
pooled percentages of HCC and non-HCC malignancy for LR-M, sources of heterogeneity between reported results
P
Orthodontic-surgical treatment patients
I/C
Conventional combined orthodontic-surgical treatment, No treatment or alternative treatments
O
Oral health-related quality of life
P
Li QL, Yao MF, Cao RY, Zhao K, Wang XD
I/C
short dental implants, splinted and nonsplinted prostheses
O
survival rates
P
South Africa, India, Turkey, Pakistan, Canada, Hong Kong, China
I/C
α-HCH, β-HCH, γ-HCH, ∑-HCH, Heptachlor, Aldrin, p,p'-DDE, p,p'-DDT, ∑-DDT, ∑-OCP, Surface water, Drinking water, Seawater, Groundwater
O
Concentration and prevalence of POPs, Carcinogenic risk, Non-carcinogenic risk
P
Chinese children under 18 years old
I/C
urban vs. rural areas, Northern China vs. Southern China, Hong Kong, Macau and Taiwan vs. mainland China
O
prevalence of refractive error (myopia, high myopia, hyperopia, astigmatism)
P
Individuals participating in blood flow restriction (BFR) training
I/C
BFR training, High-intensity resistance training (HIRT)
O
Muscular strength, hypertrophy, and endurance
P
red yeast rice preparations
I/C
RYR preparations, control treatments
O
adverse health outcomes